SCOPOLAMINE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 7 adverse event reports in the FDA FAERS database where SCOPOLAMINE was used for Psoriasis.
Most Reported Side Effects for SCOPOLAMINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 418 | 15.2% | 15 | 37 |
| Nausea | 313 | 11.4% | 3 | 69 |
| Dizziness | 293 | 10.7% | 1 | 39 |
| Product adhesion issue | 254 | 9.3% | 0 | 3 |
| Drug ineffective | 231 | 8.4% | 0 | 36 |
| Vision blurred | 212 | 7.7% | 1 | 15 |
| Vomiting | 201 | 7.3% | 3 | 61 |
| Product quality issue | 189 | 6.9% | 1 | 1 |
| Mydriasis | 180 | 6.6% | 1 | 29 |
| Product use in unapproved indication | 163 | 5.9% | 4 | 19 |
| Headache | 158 | 5.8% | 1 | 26 |
| Wrong technique in product usage process | 157 | 5.7% | 3 | 4 |
| Dry mouth | 156 | 5.7% | 3 | 12 |
| Confusional state | 146 | 5.3% | 7 | 41 |
| Hallucination | 120 | 4.4% | 1 | 31 |
Other Indications for SCOPOLAMINE
Product used for unknown indication (833)
Motion sickness (436)
Nausea (318)
Salivary hypersecretion (204)
Vertigo (128)
Dizziness (87)
Vomiting (64)
Procedural nausea (55)
Drooling (52)
Prophylaxis of nausea and vomiting (50)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)